Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinbo Qiao

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Medical Sciences|January 4, 2021
Clinical Implications of <i>HSC70</i> Expression in Clear Cell Renal Cell CarcinomaYixiao Zhang, Xudong Zhu, Xinbo Qiao, et al.
Molecular Cancer|January 10, 2023
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancerFei Xing, Hongli Gao, Guanglei Chen, et al.
International Journal of Medical Sciences|November 9, 2020
FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosisYixiao Zhang, Xudong Zhu, Xinbo Qiao, et al.
Journal of Cellular and Molecular Medicine|July 4, 2020
LIPH promotes metastasis by enriching stem-like cells in triple-negative breast cancerYixiao Zhang, Xudong Zhu, Xinbo Qiao, et al.
Journal of Cancer|November 19, 2019
Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast CancerXudong Zhu, Jinqi Xue, Xi Gu, et al.
Frontiers in Pharmacology|April 18, 2022
NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver CancerTaofei Zeng, Guanglei Chen, Xinbo Qiao, et al.
International Journal of Medical Sciences|October 6, 2025
Erratum: <i>CEMIP</i> as a potential biomarker and therapeutic target for breast cancer patients: ErratumJinqi Xue, Xudong Zhu, Xinbo Qiao, et al.
International Journal of Medical Sciences|April 4, 2022
<i>CEMIP</i> as a potential biomarker and therapeutic target for breast cancer patientsJinqi Xue, Xudong Zhu, Xinbo Qiao, et al.
Oncotargets and Therapy|September 4, 2018
The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patientsZhijing Na, Xinbo Qiao, Xuanyu Hao, et al.
Signal Transduction and Targeted Therapy|November 26, 2024
Epigenetics-targeted drugs: current paradigms and future challengesWanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Medical Sciences|January 4, 2021
Clinical Implications of <i>HSC70</i> Expression in Clear Cell Renal Cell CarcinomaYixiao Zhang, Xudong Zhu, Xinbo Qiao, et al.
Molecular Cancer|January 10, 2023
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancerFei Xing, Hongli Gao, Guanglei Chen, et al.
International Journal of Medical Sciences|November 9, 2020
FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosisYixiao Zhang, Xudong Zhu, Xinbo Qiao, et al.
Journal of Cellular and Molecular Medicine|July 4, 2020
LIPH promotes metastasis by enriching stem-like cells in triple-negative breast cancerYixiao Zhang, Xudong Zhu, Xinbo Qiao, et al.
Journal of Cancer|November 19, 2019
Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast CancerXudong Zhu, Jinqi Xue, Xi Gu, et al.
Frontiers in Pharmacology|April 18, 2022
NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver CancerTaofei Zeng, Guanglei Chen, Xinbo Qiao, et al.
International Journal of Medical Sciences|October 6, 2025
Erratum: <i>CEMIP</i> as a potential biomarker and therapeutic target for breast cancer patients: ErratumJinqi Xue, Xudong Zhu, Xinbo Qiao, et al.
International Journal of Medical Sciences|April 4, 2022
<i>CEMIP</i> as a potential biomarker and therapeutic target for breast cancer patientsJinqi Xue, Xudong Zhu, Xinbo Qiao, et al.
Oncotargets and Therapy|September 4, 2018
The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patientsZhijing Na, Xinbo Qiao, Xuanyu Hao, et al.
Signal Transduction and Targeted Therapy|November 26, 2024
Epigenetics-targeted drugs: current paradigms and future challengesWanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Pageof 3